...
首页> 外文期刊>Prescrire international >Vinpocetine: teratogenic
【24h】

Vinpocetine: teratogenic

机译:Vinpocetine:致畸

获取原文
获取原文并翻译 | 示例
           

摘要

In June 2019, the US Food and Drug Administration (FDA) issued a warning concerning the risks posed by vinpoce- tine in women who could be pregnant (1). Vinpocetine is synthetic substance derived from vincamine, an alkaloid extracted from the lesser periwinkle (2,3). It is sold with the status of a dietary supplement. It is promoted as improving cognitive performance (memory, attention, perception, etc.), boosting energy and rapidly reducing body fat, but its benefits have not been demonstrated (1,4). In animal studies, vinpocetine caused embryo loss, decreased fetal weight and congenital malformations such as cardiac ventricular septal defects, supernumerary ribs and ossification disorders. The blood levels of vinpocetine in the pregnant females were of a similar order to those observed in humans with a 10 mg dose of vinpocetine (1,5).
机译:2019年6月,美国食品和药物管理局(FDA)就长春西汀对可能怀孕的女性构成的风险发出警告(1)。长春西汀是从长春花中提取的生物碱长春胺中提取的合成物质(2,3)。它以膳食补充剂的身份出售。它被宣传为提高认知能力(记忆、注意力、感知等)、增强能量和快速减少体脂,但其益处尚未得到证实(1,4)。在动物研究中,长春西汀导致胚胎丢失、胎儿体重下降和先天性畸形,如室间隔缺损、多生肋骨和骨化障碍。怀孕女性的血液中长春西汀水平与服用10毫克长春西汀(1,5)的人类的血液中长春西汀水平相似。

著录项

  • 来源
    《Prescrire international》 |2020年第216期|共1页
  • 作者

  • 作者单位
  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号